A detailed history of Abrdn PLC transactions in Uni Qure N.V. stock. As of the latest transaction made, Abrdn PLC holds 1,929,061 shares of QURE stock, worth $12.4 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,929,061
Previous 400,480 381.69%
Holding current value
$12.4 Million
Previous $1.79 Million 430.1%
% of portfolio
0.02%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$3.78 - $10.12 $5.78 Million - $15.5 Million
1,528,581 Added 381.69%
1,929,061 $9.51 Million
Q4 2023

Jan 31, 2024

BUY
$5.63 - $8.27 $2.25 Million - $3.31 Million
400,480 New
400,480 $2.71 Million

Others Institutions Holding QURE

About uniQure N.V.


  • Ticker QURE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,729,100
  • Market Cap $300M
  • Description
  • uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...
More about QURE
Track This Portfolio

Track Abrdn PLC Portfolio

Follow Abrdn PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abrdn PLC, based on Form 13F filings with the SEC.

News

Stay updated on Abrdn PLC with notifications on news.